Literature DB >> 22345085

Extending the clinical spectrum of pain channelopathies.

Henry Houlden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22345085      PMCID： PMC3281474          DOI： 10.1093/brain/aws007

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  39 in total

1.  Rectal, ocular, and submaxillary pain; a familial autonomic disorder related to proctalgia fugaz: report of a family.

Authors:  R HAYDEN; M GROSSMAN
Journal:  AMA J Dis Child       Date:  1959-04

2.  Physiological interactions between Na(v)1.7 and Na(v)1.8 sodium channels: a computer simulation study.

Authors:  Jin-Sung Choi; Stephen G Waxman
Journal:  J Neurophysiol       Date:  2011-09-21       Impact factor: 2.714

3.  Small nerve fibres, small hands and small feet: a new syndrome of pain, dysautonomia and acromesomelia in a kindred with a novel NaV1.7 mutation.

Authors:  Janneke G J Hoeijmakers; Chongyang Han; Ingemar S J Merkies; Lawrence J Macala; Giuseppe Lauria; Monique M Gerrits; Sulayman D Dib-Hajj; Catharina G Faber; Stephen G Waxman
Journal:  Brain       Date:  2012-01-26       Impact factor: 13.501

4.  Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel.

Authors:  T R Cummins; J R Howe; S G Waxman
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

5.  Neuroscience: Channelopathies have many faces.

Authors:  Stephen G Waxman
Journal:  Nature       Date:  2011-04-14       Impact factor: 49.962

6.  Familial rectal pain.

Authors:  R E Dugan
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

7.  Type II brain sodium channel expression in non-neuronal cells: embryonic rat osteoblasts.

Authors:  J A Black; R E Westenbroek; W A Catterall; S G Waxman
Journal:  Brain Res Mol Brain Res       Date:  1995-12-01

8.  A stop codon mutation in SCN9A causes lack of pain sensation.

Authors:  Sultan Ahmad; Leif Dahllund; Anders B Eriksson; Dennis Hellgren; Urban Karlsson; Per-Eric Lund; Inge A Meijer; Luc Meury; Tracy Mills; Adrian Moody; Anne Morinville; John Morten; Dajan O'donnell; Carina Raynoschek; Hugh Salter; Guy A Rouleau; Johannes J Krupp
Journal:  Hum Mol Genet       Date:  2007-06-27       Impact factor: 6.150

9.  A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.

Authors:  Tanya Z Fischer; Elaine S Gilmore; Mark Estacion; Emmanuella Eastman; Sean Taylor; Michel Melanson; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Ann Neurol       Date:  2009-06       Impact factor: 10.422

10.  Na Channel β Subunits: Overachievers of the Ion Channel Family.

Authors:  William J Brackenbury; Lori L Isom
Journal:  Front Pharmacol       Date:  2011-09-28       Impact factor: 5.810
View more
  3 in total

1.  Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.

Authors:  Voraluck Phatarakijnirund; Steven Mumm; William H McAlister; Deborah V Novack; Deborah Wenkert; Karen L Clements; Michael P Whyte
Journal:  Bone       Date:  2015-12-31       Impact factor: 4.398

2.  Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.

Authors:  María Sereno; Gerardo Gutiérrez-Gutiérrez; Juan Moreno Rubio; María Apellániz-Ruiz; Lara Sánchez-Barroso; Enrique Casado; Sandra Falagan; Miriam López-Gómez; María Merino; César Gómez-Raposo; Nuria Rodriguez-Salas; Francisco Zambrana Tébar; Cristina Rodríguez-Antona
Journal:  BMC Cancer       Date:  2017-01-19       Impact factor: 4.430

3.  PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.

Authors:  Alice R Gardiner; Kailash P Bhatia; Maria Stamelou; Russell C Dale; Manju A Kurian; Susanne A Schneider; G M Wali; Tim Counihan; Anthony H Schapira; Sian D Spacey; Enza-Maria Valente; Laura Silveira-Moriyama; Hélio A G Teive; Salmo Raskin; Josemir W Sander; Andrew Lees; Tom Warner; Dimitri M Kullmann; Nicholas W Wood; Michael Hanna; Henry Houlden
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.